Denali Therapeutics logo

Denali Therapeutics Funding & Investors

Denali Therapeutics Inc. operates as a biotechnology company. The Company discovers and develops medicines for neurodegenerative diseases. Denali Therapeutics serves patients in the State of California.

denalitherapeutics.com

Total Amount Raised: $133,500,000

Denali Therapeutics Funding Rounds

  • Series D

    $70,000,000

    Series D Investors

    Casdin Capital
    Cormorant Asset Management
    Perceptive Advisors
    Redmile Group
    Venrock
    Wellington Management
    Tekla Capital Management
    Deerfield Management
  • Series C

    $20,000,000

    Series C Investors

    Pfizer Venture Investments
    Third Rock Ventures
    Canaan Partners
    Roche Venture Fund
  • IPO

    Unknown

  • Series B

    $11,000,000

    Series B Investors

    Canaan Partners
    Third Rock Ventures
  • Series B

    $30,000,000

    Series B Investors

    Third Rock Ventures
    Roche Venture Fund
  • Convertible Note

    $2,500,000

    Convertible Note Investors

    Mike Panesis
Funding info provided by Diffbot.